Navigation Links
China Pharma Holdings, Inc. Announces Participation in September Conferences
Date:9/1/2009

HAIKOU CITY, China, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced it will participate in the following conferences:

    -- Rodman & Renshaw Annual Global Investment Conference, held September
       9-11, 2009 at the New York Palace Hotel in New York City.  Management
       is currently scheduled to meet with institutional investors and to
       present at 12:30 pm ET on Wednesday, September 9, 2009.
    -- Maxim 3rd Annual Growth Conference, held September 29, 2009 at the
       Grand Hyatt Hotel in New York City.

Live webcasts will be available via the Company's website at http://www.chinapharmaholdings.com/ . For further details, please contact your respective institutional sales representative.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit '/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. China Sky One Medical, Inc. to Present at Rodman & Renshaw Annual Global Investment Conference and Conduct Non-Deal Roadshow in the U.S.
2. China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results
3. China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results
4. China Medicine Enhances Management Team with Appointments of New Chief Financial Officer and Finance Manager
5. China Sky One Medical, Inc. to Hold Annual Meeting of Shareholders on September 24, 2009
6. Linkwell Corporation Announces Launch of the Establishment of 100 Model Hospitals Across China
7. Linkwell Corporation Announces Launch of the Series of Handwashing Contest Across China
8. China Healthcare Corp. Provides Update on JV to Build its First Hospital in China
9. China Kangtai Cactus Biotech to Attend Rodman & Renshaw Conference and Meet with Investors in September
10. China Nepstar Chain Drugstore Announces Special Dividend
11. China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 Are you tired of having ... with seasonal allergies or sinus congestion? Fortunately, an inventor ... , She conceived of Nose Pal to avoid ... nose in public. Since it prevents nasal drip and ... conditions, particularly when cooking or working closely with others. ...
(Date:9/19/2014)... (HealthDay News) -- As kids transition from elementary to ... according to a recent study. But the ... found that verbal and physical bullying declines as students ... and prevention strategies must address all types of bullying ... girls, the researchers said. The study was published recently ...
(Date:9/19/2014)... Phoenix, AZ (PRWEB) September 19, 2014 Hastings ... over 30 years in the industry, announces a record number ... firm handles a wide variety of serious injury cases as ... cases along with dog bite related accident cases and others. ... Hastings and Hastings has stood the test of time when ...
(Date:9/19/2014)... According to a report from HarrisMartin ... Xarelto, named as defendants in several lawsuits filed in ... the court to dismiss those suits because the alleged ... with Philadelphia.* The cases include, for instance, Fontan v. ... Comm. Pls., Philadelphia Cty.), which was brought by a ...
(Date:9/19/2014)... 2014 (HealthDay News) -- Your brain structure could help predict ... study suggests. Researchers at Yale University found those with ... the parietal cortex may be more likely to engage in ... , , The study, funded by the U.S. National Institute ... women living in the Northeast. The researchers sought to determine ...
Breaking Medicine News(10 mins):Health News:Nasal Drip Eliminator Invented by InventHelp Client (LCC-218) 2Health News: Cyberbullying Seems to Ramp Up in Middle School 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 3Health News:Brain Structure Might Help Predict Risky Behavior 2
... Indiana University study found that young, female breast cancer ... and are interested in using sexual enhancement products to ... Cancer Survivors: Their sexual function and interest in sexual ... the journal Cancer Nursing . , The study ...
... reduced chances by 26% , , SUNDAY, Nov. 9 (HealthDay News) ... an extra benefit: a reduction in their risk of developing ... under the age of 52, according to research that was ... in New Orleans. , The findings, the first to demonstrate ...
... to protect healthy men, either , , SUNDAY, Nov. 9 ... doubt on the cardiac benefits of either low-dose aspirin ... low-dose aspirin did not reduce the risk of cardiovascular ... Harvard researchers concluded that neither vitamin E nor vitamin ...
... Low-dose aspirin as primary prevention did not appear to ... of coronary, cerebrovascular and peripheral vascular events in patients ... in JAMA . However, aspirin did significantly reduce ... The article is being released early online Sunday, November ...
... informed its readers of serious drug reactions and fatalities, which have ... as Heparin. The drug, from Baxter Healthcare, was found to be ... ... Denver (PRWEB) November 9, 2008 -- LegalView.com, the number one legal ...
... they have risk factors that could lead to coronary ... -- Despite certain risk factors, Hispanic patients were 57 ... bypass surgery (CABG) one year after successful angioplasty to ... It also found that Hispanics were less likely to ...
Cached Medicine News:Health News:Sexual intimacy and breast cancer survivors: New research 2Health News:Flu Shots Lower Risk of Blood Clots 2Health News:Flu Shots Lower Risk of Blood Clots 3Health News:Aspirin Doesn't Guard Diabetics Against Heart Disease 2Health News:Aspirin Doesn't Guard Diabetics Against Heart Disease 3Health News:Aspirin Doesn't Guard Diabetics Against Heart Disease 4Health News:Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes 2Health News:Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes 3Health News:Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes 4Health News:LegalView Reports Record Numbers of Drug Reactions in U.S., Partially Caused by Heparin 2Health News:LegalView Reports Record Numbers of Drug Reactions in U.S., Partially Caused by Heparin 3Health News:LegalView Reports Record Numbers of Drug Reactions in U.S., Partially Caused by Heparin 4Health News:Hispanics Less Likely to Get Repeat Artery Surgery 2
(Date:9/19/2014)...  PCI is pleased to announce it has ... leading provider of Clinical Trial Services and Temperature ... Wales in the United ... presence in the UK/EU to support global investigational ... and distribution capacity, as well as consultative services ...
(Date:9/18/2014)... , Sept. 18, 2014  Low T Center ... meeting in Hyattsville, Maryland ... assess the proper patient population for testosterone therapy ... risk associated with TRT. Examining recent claims from studies ... that "available epidemiological studies do not provide convincing ...
(Date:9/18/2014)... , September 18, 2014 ... http://www.researchandmarkets.com/research/f9nkkh/sugar_alcohols ) has announced the addition of ... Report"  report to their offering.  ... the worldwide markets for Sugar Alcohols in ... Food & Confectionery, Pharmaceuticals, Cosmetics, Oral-Care Products, ...
Breaking Medicine Technology:PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2Sugar Alcohols - Global Strategic Business Report 201 2Sugar Alcohols - Global Strategic Business Report 201 3
Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility...
ManuTrain is an active wrist support that has optional features for increased stabilization....
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... 3-Point® Polycentric Hinged Ulnar Deviation Splint uses ... the hand with ulnar deviation at the ... grasp or pinch. Radial and ulnar polycentric ... unimpeded flexion and extension. Padded, malleable finger ...
Medicine Products: